New Jersey will receive $641 million from the $26 billion nationwide opioid settlement, Gov. Phil Murphy and Acting Attorney General Matthew Platkin said on Friday.
The settlement was originally announced in July 2021, and covers three major pharmaceutical distributors of opioids — McKesson, Cardinal Health, and AmerisourceBergen — as well as Johnson & Johnson, the major manufacturer of the drugs.
State officials say that the money will be allocated for use to bolster harm reduction programs, treatment strategies, and drug prevention.The money will be split evenly — 50% going to the state, and the other 50% going to individual municipalities across New Jersey.
